Literature DB >> 27558890

Atypical teratoid/rhabdoid tumours: clinicopathological characteristics, prognostic factors and outcomes of 22 children from 2010 to 2015 in China.

Rui-Fen Wang1, Wen-Bin Guan1, Yu Yan1, Bo Jiang1, Jie Ma2, Ma-Wei Jiang3, Li-Feng Wang4.   

Abstract

Atypical teratoid/rhabdoid tumours (AT/RTs) are rare, highly malignant tumours of the central nervous system (CNS) with poor prognosis that usually affect young children. The aim of this study was to assess the clinicopathological features and prognostic factors of AT/RTs. Here, we describe the clinicopathological and immunohistochemical characteristics, along with the treatments and outcomes, of 22 patients with AT/RTs treated in our hospital from 2010 to 2015. Morphologically, cytoplasmic vacuoles, the most common characteristic in our cases, were observed in 68% of the cases. Similarly, vesicular nuclei were detected in 68% of the cases. However, rhabdoid cells were found in only 59.1% of the cases and were not observed in 40.9% of the cases. Immunohistochemical analysis revealed loss of nuclear INI1 expression in all 22 cases. Age, surgical resection and adjuvant therapy, but not tumour location, were associated with AT/RTs patient prognosis. Our results showed that cells with cytoplasmic vacuoles or with vesicular nuclei are more common than rhabdoid cells in patients with AT/RTs and that a lack of INI1 protein expression is the most useful marker for the differential diagnosis of AT/RTs. Young age is a negative prognostic factor, whereas gross total surgical resection and adjuvant therapy are positive prognostic factors for AT/RT patients.
Copyright © 2016 Royal College of Pathologists of Australasia. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Atypical teratoid/rhabdoid tumour; INI1; diagnosis; immunohistochemistry

Mesh:

Substances:

Year:  2016        PMID: 27558890     DOI: 10.1016/j.pathol.2016.05.010

Source DB:  PubMed          Journal:  Pathology        ISSN: 0031-3025            Impact factor:   5.306


  4 in total

1.  Overall Survival of Primary Intracranial Atypical Teratoid Rhabdoid Tumor Following Multimodal Treatment: A Pooled Analysis of Individual Patient Data.

Authors:  Xiu-Jian Ma; Da Li; Liang Wang; Shu-Yu Hao; Li-Wei Zhang; Jun-Ting Zhang; Zhen Wu
Journal:  Neurosurg Rev       Date:  2018-12-08       Impact factor: 3.042

2.  Multimodal treatments combined with gamma knife surgery for primary atypical teratoid/rhabdoid tumor of the central nervous system: a single-institute experience of 18 patients.

Authors:  Yan-Ming Ren; Xia Wu; Chao You; Yue-Kang Zhang; Qiang Li; Yan Ju
Journal:  Childs Nerv Syst       Date:  2017-12-07       Impact factor: 1.475

3.  The identification of miRNA and mRNA expression profiles associated with pediatric atypical teratoid/rhabdoid tumor.

Authors:  Xinke Xu; Hongyao Yuan; Junping Pan; Wei Chen; Cheng Chen; Yang Li; Fangcheng Li
Journal:  BMC Cancer       Date:  2022-05-06       Impact factor: 4.638

4.  Histopathological patterns in atypical teratoid/rhabdoid tumors are related to molecular subgroup.

Authors:  Francesca Zin; Jennifer A Cotter; Christine Haberler; Matthias Dottermusch; Julia Neumann; Ulrich Schüller; Leonille Schweizer; Christian Thomas; Karolina Nemes; Pascal D Johann; Marcel Kool; Michael C Frühwald; Werner Paulus; Alexander Judkins; Martin Hasselblatt
Journal:  Brain Pathol       Date:  2021-05-03       Impact factor: 6.508

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.